FDA DEVICE FACTS
ACTIFY™ Unicondylar Knee System
Globus Medical, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The ACTIFY™ Unicondylar Knee System is indicated for unicompartmental knee replacement due to the following conditions:
1. Moderately disabling joint disease of the knee resulting from painful osteo- and/or post-traumatic arthritis, or avascular necrosis.
2. Revision of previous unsuccessful unicompartmental knee replacement or other procedure.
3. Alternative to tibial osteotomy in patients with unicompartmental osteoarthritis.
4. Previous tibial condyle or plateau fractures with loss of anatomy or function.
5. Varus or valgus deformities.
These devices are indicated for cemented use only.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。